The Community Guide

- gsearch

Search Results

Narrow Results:

2021 1
2019 1
2018 1
2017 1
2015 1
2013 1
2011 1
1997 1
1994 1
1993 1
1992 1

Journal Article 7
Journal Issue 4

Statistics 1

1 - 11 of 11 Results

Refine Results

Refine Results:

Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies

CITE Title : Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies Personal Author(s) : Lin, Lin;Chan, Cliburn;Hadrup, Sine R.;Froesig, Thomas M.;Wang, Quanli;West, Mike; Published Date : Jun 2013 Source : Stat Appl Genet Mol Biol. 12(3):309-331. URL : https://stacks.cdc.gov/view/cdc/41981 Lin, Lin et al. (2013). Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies. 12(3). Lin, Lin et al. "Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies" 12, no. 3 (2013) Lin, Lin et al. "Hierarchical Bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies" vol. 12, no. 3, 2013 Export RIS Citation Information.

:

Lin, Lin ;

Chan, Cliburn

Jun 2013 | Stat Appl Genet Mol Biol. 12(3):309-331.

:

Novel uses of automated flow cytometry technology for measuring levels of protein markers on thousands to millions of cells are promoting increasing n...
B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus

CITE Title : B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus Personal Author(s) : Jenks, Scott A;Wei, Chungwen;Bugrovsky, Regina;Hill, Aisha;Wang, Xiaoqian;Rossi, Francesca M;Cashman, Kevin;Woodruff, Matthew C;Aspey, Laura D;Lim, S. Sam;Bao, Gaobin;Drenkard, Cristina;Sanz, Ignacio; Published Date : 9 2021 Source : Ann Rheum Dis. 80(9):1190-1200 URL : https://stacks.cdc.gov/view/cdc/115356 Jenks, Scott A et al. (2021). B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus. 80(9). Jenks, Scott A et al. "B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus" 80, no. 9 (2021) Jenks, Scott A et al. "B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus" vol. 80, no. 9, 2021 Export RIS Citation Information.

:

Jenks, Scott A ;

Wei, Chungwen

9 2021 | Ann Rheum Dis. 80(9):1190-1200

:

ObjectiveWhile the contribution of B-cells to SLE is well established, its role in chronic cutaneous lupus erythematosus (CCLE) remains unclear. Here,...
Surface area- and mass-based comparison of fine and ultrafine nickel oxide lung toxicity and augmentation of allergic response in an ovalbumin asthma model

CITE Title : Surface area- and mass-based comparison of fine and ultrafine nickel oxide lung toxicity and augmentation of allergic response in an ovalbumin asthma model Personal Author(s) : Roach, Katherine A.;Anderson, Stacey E.;Stefaniak, Aleksandr B.;Shane, Hillary L.;Kodali, Vamsi;Kashon, Michael;Roberts, Jenny R.; Published Date : November 11 2019 Source : Inhal Toxicol. 31(8):299-324 URL : https://stacks.cdc.gov/view/cdc/99059 Roach, Katherine A. et al. (2019). Surface area- and mass-based comparison of fine and ultrafine nickel oxide lung toxicity and augmentation of allergic response in an ovalbumin asthma model. 31(8). Roach, Katherine A. et al. "Surface area- and mass-based comparison of fine and ultrafine nickel oxide lung toxicity and augmentation of allergic response in an ovalbumin asthma model" 31, no. 8 (2019) Roach, Katherine A. et al. "Surface area- and mass-based comparison of fine and ultrafine nickel oxide lung toxicity and augmentation of allergic response in an ovalbumin asthma model" vol. 31, no. 8, 2019 Export RIS Citation Information.

:

Roach, Katherine A. ;

Anderson, Stacey E.

November 11 2019 | Inhal Toxicol. 31(8):299-324

:

Background:The correlation of physico-chemical properties with mechanisms of toxicity has been proposed as an approach to predict the toxic potential ...
Stereotactic Ablative Radiotherapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site

CITE Title : Stereotactic Ablative Radiotherapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site Personal Author(s) : McGee, Heather M.;Daly, Megan E.;Azghadi, Sohelia;Stewart, Susan L.;Oesterich, Leslie;Schlom, Jeffrey;Donahue, Renee;Schoenfeld, Jonathan D.;Chen, Qian;Rao, Shyam;Fragoso, Ruben C.;Valicenti, Richard K.;Canter, Robert J.;Maverakis, Emmanual M.;Murphy, William J.;Kelly, Karen;Monjazeb, Arta M.; Published Date : April 22 2018 Source : Int J Radiat Oncol Biol Phys. 101(5):1259-1270 URL : https://stacks.cdc.gov/view/cdc/80361 McGee, Heather M. et al. (2018). Stereotactic Ablative Radiotherapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. 101(5). McGee, Heather M. et al. "Stereotactic Ablative Radiotherapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site" 101, no. 5 (2018) McGee, Heather M. et al. "Stereotactic Ablative Radiotherapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site" vol. 101, no. 5, 2018 Export RIS Citation Information.

:

McGee, Heather M. ;

Daly, Megan E.

April 22 2018 | Int J Radiat Oncol Biol Phys. 101(5):1259-1270

:

Purpose/Objective(s):Despite strong interest in combining stereotactic ablative radiotherapy (SAR) with immunotherapy, limited data characterize the s...
Detection of Minimal Residual Disease in B Lymphoblastic Leukemia Using viSNE

CITE Title : Detection of Minimal Residual Disease in B Lymphoblastic Leukemia Using viSNE Personal Author(s) : DiGiuseppe, Joseph A.;Tadmor, Michelle D.;Pe’er, Dana; Published Date : 2015;Sep-Oct 2015; Source : Cytometry B Clin Cytom. 88(5):294-304 URL : https://stacks.cdc.gov/view/cdc/55388 DiGiuseppe, Joseph A. et al. (2015). Detection of Minimal Residual Disease in B Lymphoblastic Leukemia Using viSNE. 88(5). DiGiuseppe, Joseph A. and Tadmor, Michelle D. and Pe’er, Dana "Detection of Minimal Residual Disease in B Lymphoblastic Leukemia Using viSNE" 88, no. 5 (2015) DiGiuseppe, Joseph A. et al. "Detection of Minimal Residual Disease in B Lymphoblastic Leukemia Using viSNE" vol. 88, no. 5, 2015 Export RIS Citation Information.

:

DiGiuseppe, Joseph A. ;

Tadmor, Michelle D.

2015 | Cytometry B Clin Cytom. 88(5):294-304

:

BackgroundMinimal residual disease (MRD) following treatment is a robust prognostic marker in B lymphoblastic leukemia. However, the detection of MRD ...
Role of Germination in Murine Airway CD8+ T-Cell Responses to Aspergillus Conidia

CITE Title : Role of Germination in Murine Airway CD8+ T-Cell Responses to Aspergillus Conidia Personal Author(s) : Templeton, Steven P.;Buskirk, Amanda D.;Law, Brandon;Green, Brett J.;Beezhold, Donald H.; Published Date : Apr 13 2011 Source : PLoS One. 6(4). URL : https://stacks.cdc.gov/view/cdc/4321 Templeton, Steven P. et al. (2011). Role of Germination in Murine Airway CD8+ T-Cell Responses to Aspergillus Conidia. 6(4). Templeton, Steven P. et al. "Role of Germination in Murine Airway CD8+ T-Cell Responses to Aspergillus Conidia" 6, no. 4 (2011) Templeton, Steven P. et al. "Role of Germination in Murine Airway CD8+ T-Cell Responses to Aspergillus Conidia" vol. 6, no. 4, 2011 Export RIS Citation Information.

:

Templeton, Steven P. ;

Buskirk, Amanda D.

Apr 13 2011 | PLoS One. 6(4).

:

Pulmonary exposure to Aspergillus fumigatus has been associated with morbidity and mortality, particularly in immunocompromised individuals. A. fumiga...
Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide

CITE Title : Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide Personal Author(s) : Shane, Hillary L.;Lukomska, Ewa;Stefaniak, Aleksandr B.;Anderson, Stacey E.; Published Date : 12 2017;12-2017; Source : J Immunotoxicol. 14(1):204-214 URL : https://stacks.cdc.gov/view/cdc/76269 Shane, Hillary L. et al. (2017). Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide. 14(1). Shane, Hillary L. et al. "Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide" 14, no. 1 (2017) Shane, Hillary L. et al. "Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide" vol. 14, no. 1, 2017 Export RIS Citation Information.

:

Shane, Hillary L. ;

Lukomska, Ewa

12 2017 | J Immunotoxicol. 14(1):204-214

:

Didecyldimethylammonium bromide (DDAB) is a fourth generation dialkyl-quaternary ammonium compound (QAC) that is used in numerous products for its ant...
1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV)

CITE Title : 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV) Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : January 10, 1997 Pages in Document : 29 pdf pages Series : Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-2):1-29. URL : https://stacks.cdc.gov/view/cdc/7373 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports Centers for Disease Control and Prevention (U.S.) (1997). 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). 46(2). Centers for Disease Control and Prevention (U.S.) "1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV)" 46, no. 2 (1997) Centers for Disease Control and Prevention (U.S.) "1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV)" vol. 46, no. 2, 1997 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

January 10, 1997 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

:

Human immunodeficiency virus counseling and testing services (HIV-CTS) have been recommended by CDC since 1985, when serologic tests became available ...
MMWR. Morbidity and Mortality Weekly Report, Vol. 42, No. 38, October 1, 1993

CITE Title : MMWR. Morbidity and Mortality Weekly Report, Vol. 42, No. 38, October 1, 1993 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : October 1, 1993 Pages in Document : p. 733 - 756 Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 1993; v. 42, no. 38 URL : https://stacks.cdc.gov/view/cdc/26840 Journal Title : MMWR. Morbidity and Mortality Weekly Report Centers for Disease Control and Prevention (U.S.) (1993). MMWR. Morbidity and Mortality Weekly Report, Vol. 42, No. 38, October 1, 1993. 42(38). Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 42, No. 38, October 1, 1993" 42, no. 38 (1993) Centers for Disease Control and Prevention (U.S.) "MMWR. Morbidity and Mortality Weekly Report, Vol. 42, No. 38, October 1, 1993" vol. 42, no. 38, 1993 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

October 1, 1993 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description
1994 Revised Guidelines for the Performance of CD4+ T-cell Determinations in Persons with Human Immunodeficiency Virus (HIV) Infections

CITE Title : 1994 Revised Guidelines for the Performance of CD4+ T-cell Determinations in Persons with Human Immunodeficiency Virus (HIV) Infections Personal Author(s) : Nicholson, Janet K. A., 1948-;McDougal, J. Steven;Hearn, Thomas L.;Collins, Carlyn L.;Velleca, Wallis M.;Jones, Wanda K.;Gerber, A. Russell; Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Public Health Practice Program Office.;National Center for Infectious Diseases (U.S.);National Center for Prevention Services (U.S.); Published Date : March 4, 1994 Pages in Document : 26 pdf pages Series : Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 1994; v. 43, no. 3 URL : https://stacks.cdc.gov/view/cdc/7358 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports Nicholson, Janet K. A., 1948- et al. (1994). 1994 Revised Guidelines for the Performance of CD4+ T-cell Determinations in Persons with Human Immunodeficiency Virus (HIV) Infections. 43(3). Nicholson, Janet K. A., 1948- et al. "1994 Revised Guidelines for the Performance of CD4+ T-cell Determinations in Persons with Human Immunodeficiency Virus (HIV) Infections" 43, no. 3 (1994) Nicholson, Janet K. A., 1948- et al. "1994 Revised Guidelines for the Performance of CD4+ T-cell Determinations in Persons with Human Immunodeficiency Virus (HIV) Infections" vol. 43, no. 3, 1994 Export RIS Citation Information.

:

Nicholson, Janet K. A., 1948- ;

McDougal, J. Steven

March 4, 1994 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

:

The Food and Drug Administration (FDA) has recommended that all donated blood be screened for antibodies to human immunodeficiency virus type 2 (HIV-2...
Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus Infection

CITE Title : Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus Infection Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : May 8, 1992 Pages in Document : 13 pdf pages Series : Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR) Source : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 1992; v. 41, no. 8 URL : https://stacks.cdc.gov/view/cdc/7300 Journal Title : Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports Centers for Disease Control and Prevention (U.S.) (1992). Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus Infection. 41(8). Centers for Disease Control and Prevention (U.S.) "Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus Infection" 41, no. 8 (1992) Centers for Disease Control and Prevention (U.S.) "Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus Infection" vol. 41, no. 8, 1992 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

May 8, 1992 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)

:

This document has been developed by CDC to give guidance to laboratories performing lymphocyte immunophenotyping assays in human immunodeficiency viru...

:

superseded